Catherine Moukheibir, director at MoonLake Immunotherapeutics (MLTX), sold $1.1 million in company shares through one open market transaction on July 3, 2025, with no purchases in the last year. Her sales volume ranks 4608th among 11,678 insiders, trailing the average of $8.6 million per seller across about 6.4 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 3, 2025 | MoonLake Immunotherapeutics | $MLTX | Moukheibir Catherine | Director | M | Class A ordinary shares, par value $0.0001 per share | 23500 | $0.00 | 23,500.0000 | 62,870,237 | 9999.99% | 0.04% |
| July 3, 2025 | MoonLake Immunotherapeutics | $MLTX | Moukheibir Catherine | Director | M | Option to Buy | 23500 | $0.00 | 21,500.0000 | 62,870,237 | 52.22% | 0.04% |
| July 3, 2025 | MoonLake Immunotherapeutics | $MLTX | Moukheibir Catherine | Director | S | Class A ordinary shares, par value $0.0001 per share | 23500 | $48.79 | 0.0000 | 62,870,237 | 100.00% | 0.04% |
| June 10, 2025 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Moukheibir Catherine | Not found | A | Class A Common Stock | 45000 | $0.00 | 117,944.0000 | 160,974,000 | 61.69% | 0.03% |
| June 5, 2025 | MoonLake Immunotherapeutics | $MLTX | Moukheibir Catherine | Director | A | Option to Buy | 6682 | $0.00 | 6,682.0000 | 62,870,237 | 9999.99% | 0.01% |
| June 18, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Moukheibir Catherine | Not found | A | Class A Common Stock | 24311 | $0.00 | 72,944.0000 | 157,700,000 | 49.99% | 0.02% |
| June 7, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Moukheibir Catherine | Not found | S | Class A Common Stock | 35574 | $6.61 | 48,633.0000 | 157,700,000 | 42.25% | 0.02% |
| June 6, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Moukheibir Catherine | Not found | S | Class A Common Stock | 44426 | $6.36 | 84,207.0000 | 157,700,000 | 34.54% | 0.03% |
| June 6, 2024 | MoonLake Immunotherapeutics | $MLTX | Moukheibir Catherine | Director | A | Option to Buy | 7688 | $0.00 | 7,688.0000 | 49,122,534 | 9999.99% | 0.02% |
| Dec. 15, 2023 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Moukheibir Catherine | Director | A | Class A Common Stock | 1572 | $0.00 | 128,633.0000 | 186,891,000 | 1.24% | 0.00% |
| Sept. 15, 2023 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Moukheibir Catherine | Director | A | Class A Common Stock | 2098 | $0.00 | 127,061.0000 | 155,367,000 | 1.68% | 0.00% |
| June 20, 2023 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Moukheibir Catherine | Director | A | Class A Common Stock | 22350 | $0.00 | 124,963.0000 | 186,680,000 | 21.78% | 0.01% |
| June 15, 2023 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Moukheibir Catherine | Director | A | Class A Common Stock | 1586 | $0.00 | 102,613.0000 | 186,680,000 | 1.57% | 0.00% |
| March 15, 2023 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Moukheibir Catherine | Director | A | Class A Common Stock | 1677 | $0.00 | 101,027.0000 | 186,312,000 | 1.69% | 0.00% |